Navigating COVID Treatments and Political Challenges

This chapter covers recent developments in COVID treatments, particularly new medications from Merck and Pfizer, while addressing concerns about their pricing. It also explores the influence of pharmaceutical lobbyists and the nuances of political messaging to gain public support for legislation. Additionally, the discussion touches on the challenges faced by families, the impact of social media on parenting, and the need for bipartisan solutions to create a fair digital landscape.